Using an agent-based model to analyze the dynamic communication network of the immune response.
BACKGROUND
The immune system behaves like a complex, dynamic network with interacting elements including leukocytes, cytokines, and chemokines. While the immune system is broadly distributed, leukocytes must communicate effectively to respond to a pathological challenge. The Basic Immune Simulator 2010 contains agents representing leukocytes and tissue cells, signals representing cytokines, chemokines, and pathogens, and virtual spaces representing organ tissue, lymphoid tissue, and blood. Agents interact dynamically in the compartments in response to infection of the virtual tissue. Agent behavior is imposed by logical rules derived from the scientific literature. The model captured the agent-to-agent contact history, and from this the network topology and the interactions resulting in successful versus failed viral clearance were identified. This model served to integrate existing knowledge and allowed us to examine the immune response from a novel perspective directed at exploiting complex dynamics, ultimately for the design of therapeutic interventions.


RESULTS
Analyzing the evolution of agent-agent interactions at incremental time points from identical initial conditions revealed novel features of immune communication associated with successful and failed outcomes. There were fewer contacts between agents for simulations ending in viral elimination (win) versus persistent infection (loss), due to the removal of infected agents. However, early cellular interactions preceded successful clearance of infection. Specifically, more Dendritic Agent interactions with TCell and BCell Agents, and more BCell Agent interactions with TCell Agents early in the simulation were associated with the immune win outcome. The Dendritic Agents greatly influenced the outcome, confirming them as hub agents of the immune network. In addition, unexpectedly high frequencies of Dendritic Agent-self interactions occurred in the lymphoid compartment late in the loss outcomes.


CONCLUSIONS
An agent-based model capturing several key aspects of complex system dynamics was used to study the emergent properties of the immune response to viral infection. Specific patterns of interactions between leukocyte agents occurring early in the response significantly improved outcome. More interactions at later stages correlated with persistent inflammation and infection. These simulation experiments highlight the importance of commonly overlooked aspects of the immune response and provide insight into these processes at a resolution level exceeding the capabilities of current laboratory technologies.
Department of Internal Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, The Ohio State University Medical Center, Davis Heart and Lung Research Institute, Columbus, OH, USA. nivar.1@osu.edu
Virginia A
VA
Folcik
Gordon
G
Broderick
Shunmugam
S
Mohan
Brian
B
Block
Chirantan
C
Ekbote
John
J
Doolittle
Marc
M
Khoury
Luke
L
Davis
Clay B
CB
Marsh
D003198:Computer Simulation; D007107:Immune System / Q000502:physiology*; D012984:Software
Eur J Immunol. 2001 Mar;31(3):959-65
11241301
Annu Rev Immunol. 2005;23:197-223
15771570
Genomics. 2008 Dec;92(6):393-9
18775774
Ann N Y Acad Sci. 1997 Dec 15;832:426-48
9704069
Nat Immunol. 2009 Jul;10(7):689-95
19536194
Science. 1998 Jul 3;281(5373):96-9
9651253
Nat Immunol. 2003 Jun;4(6):579-85
12730692
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2604-9
12601158
Int Immunol. 2004 Aug;16(8):1133-42
15237106
Nature. 2006 May 11;441(7090):235-8
16648838
J Immunol. 2003 Nov 15;171(10):4969-73
14607890
Nat Immunol. 2007 Jan;8(1):11-3
17179963
AJR Am J Roentgenol. 1986 Sep;147(3):469-72
3488647
J Clin Invest. 1998 Feb 15;101(4):890-8
9466984
N Engl J Med. 2007 Jul 26;357(4):404-7
17652657
Nature. 1998 Jun 4;393(6684):478-80
9624004
Nature. 1998 Mar 19;392(6673):245-52
9521319
Nat Rev Immunol. 2006 Jul;6(7):497-507
16799470
Nature. 2004 Jan 8;427(6970):154-9
14712275
J Exp Med. 1998 Jan 5;187(1):1-14
9419206
J Immunol. 2004 Jul 15;173(2):955-61
15240682
Nat Immunol. 2005 Nov;6(11):1133-41
16200068
Wiley Interdiscip Rev Syst Biol Med. 2010 Jan-Feb;2(1):107-116
20836014
Thorax. 1982 Sep;37(9):676-9
6760448
J Exp Med. 2003 Oct 6;198(7):1069-76
14530376
Proc Natl Acad Sci U S A. 2004 Jan 27;101(4):998-1003
14722354
Nat Rev Genet. 2004 Feb;5(2):101-13
14735121
Nature. 2008 May 1;453(7191):65-71
18362915
Nature. 2003 Oct 2;425(6957):516-21
14520412
Nat Med. 1999 Nov;5(11):1249-55
10545990
Bioinformatics. 2005 Apr 15;21(8):1639-43
15613387
Trends Immunol. 2003 Sep;24(9):474-8
12967670
J Exp Med. 2005 Jan 17;201(2):233-40
15657292
Nature. 2000 Jul 27;406(6794):378-82
10935628
J Immunol. 2008 May 1;180(9):5771-7
18424693
Immunome Res. 2008 Apr 22;4:4
18430195
Immunity. 2000 Nov;13(5):715-25
11114383
Lymphat Res Biol. 2003;1(3):219-34
15624439
Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 2):S5-11
10556161
Nature. 1998 Jun 4;393(6684):474-8
9624003
J Thorac Oncol. 2009 May;4(5):568-77
19357537
J Exp Med. 1997 Jun 16;185(12):2133-41
9182685
Science. 2009 Jul 24;325(5939):412-3
19628854
PLoS Genet. 2006 Jun 2;2(6):e88
16751849
Autoimmun Rev. 2005 Nov;4(8):491-6
16214084
J Leukoc Biol. 2005 Jun;77(6):886-92
15728244
Immunity. 2005 Jan;22(1):19-29
15664156
Microbes Infect. 2004 Jul;6(8):745-51
15207821
J Exp Med. 1996 Aug 1;184(2):741-6
8760828
J Leukoc Biol. 1999 Aug;66(2):224-30
10449158
PLoS Comput Biol. 2009 Apr;5(4):e1000353
19360091
J Immunol. 2000 May 1;164(9):4507-12
10779751
Nature. 2006 May 11;441(7090):231-4
16648837
Sci Am. 2003 May;288(5):60-9
12701331
J Immunol. 2007 Dec 15;179(12):8180-90
18056361
J Exp Med. 2000 Aug 7;192(3):405-12
10934228
Immunol Rev. 2009 Jan;227(1):75-86
19120477
Curr Opin Immunol. 2006 Aug;18(4):391-8
16765573
Theor Biol Med Model. 2008 May 27;5:11
18505587
Science. 2004 Nov 26;306(5701):1555-8
15567862
Science. 1999 Oct 15;286(5439):509-12
10521342
J Crit Care. 2006 Mar;21(1):105-10; discussion 110-1
16616634
Nat Immunol. 2006 Apr;7(4):329-32
16550194
Nat Immunol. 2008 Oct;9(10):1179-88
18776906
Mol Immunol. 2005 Feb;42(4):501-10
15607806
Nature. 2000 Oct 5;407(6804):651-4
11034217
J Immunol. 2002 Apr 15;168(8):3697-701
11937518
Biol Direct. 2006 Oct 24;1:32
17062134
PLoS Biol. 2005 Jun;3(6):e150
15857154
J Clin Invest. 2002 Jan;109(1):41-50
11781349
J Exp Med. 2003 Sep 1;198(5):715-24
12953093
Nat Immunol. 2006 Dec;7(12):1237-42
17110939
Nat Immunol. 2004 Dec;5(12):1243-50
15543150
Immunol Rev. 2008 Dec;226:132-46
19161421
Immunol Rev. 2008 Feb;221:163-81
18275481
J Exp Med. 2006 Aug 7;203(8):1903-13
16831898
J Exp Med. 2007 Apr 16;204(4):771-80
17389236
Cell. 2001 Aug 10;106(3):255-8
11509172
J Immunol. 2004 Jul 1;173(1):68-78
15210760
Theor Biol Med Model. 2007 Sep 27;4:39
17900357
Nature. 1998 Jun 4;393(6684):480-3
9624005
Proc Natl Acad Sci U S A. 2007 May 22;104(21):8685-90
17502601
PLoS Comput Biol. 2005 Dec;1(7):e68
16362071
PLoS Comput Biol. 2008 Aug 01;4(8):e1000140
18670624
Nat Immunol. 2000 Sep;1(3):199-205
10973276
Eur Respir J. 2006 Aug;28(2):268-74
16510453
Nature. 2010 Mar 4;464(7285):104-7
20203610
Blood. 1997 Nov 1;90(9):3245-87
9345009
Ann Emerg Med. 2006 Jul;48(1):28-54
16781920
Nat Rev Immunol. 2002 Mar;2(3):185-94
11913069
Curr Opin Immunol. 2005 Jun;17(3):244-50
15886113
Nat Immunol. 2005 Nov;6(11):1123-32
16200070